Malvern extends contract particle characterisation services in North America through an agreement with Particle Technology Laboratories in Chicago
Malvern Instruments has entered into an agreement with Particle Technology Laboratories (PTL) that will enable it to extend its contract testing services for customers in North America.
Malvern's contract services for particle characterisation are well-established and will continue to be initiated and managed by the company's experienced team.
However, the testing itself will now be carried out by PTL at its facility in Chicago.
Particle Technology Labs is described as a leading independent laboratory specialising in fine particle size and characterisation services.
It has FDA registration, a DEA licence and ATF permits, and follows cGMP guidelines.
Jane Bishop, commercial director at Malvern, said: "We are delighted to welcome Particle Technology Labs as a partner for our contract services in North America.
"Their vast expertise and experience in fine particle characterisation will support us in extending the contract services that Malvern provides in this area.
"PTL's FDA registration brings additional benefits and security for our pharmaceutical clients".
Richard Karuhn, founder and CEO of PTL said: "We have relied upon Malvern particle characterisation systems for many years and are very pleased to have the opportunity to extend our relationship with the company.
"I am confident that combining our expertise in particle characterisation will not only be of benefit to Malvern's existing contract services customers, but will also prove attractive to new clients."
